Literature DB >> 7047113

Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.

J A Galloway, C T Spradlin, R L Nelson, S M Wentworth, J A Davidson, J L Swarner.   

Abstract

Normal fasting subjects received regular insulin and mixtures of regular with NPH or lente to assess the effects of the combinations on serum insulin concentrations (SIC) and blood glucose responses (BGR). In addition, the influence of concentration, depth, and method and site of administration was investigated. In studies of mixtures of regular with NPH and with lente, it was observed that the regular: lente ratio needed to achieve peak SIC was higher than with the regular: NPH combination. Increased SIC, including either the peak and/or the time interval required to achieve the peak, were related to the depth and site (deltoid and abdominal greater than anterior thigh or buttocks). Assuming linear kinetics of absorption, significant quantities of insulin fail to reach the serum. Marked intra- and intersubject variations in SIC and BGR to regular, NPH, and lente insulins were observed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7047113     DOI: 10.2337/diacare.4.3.366

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  49 in total

1.  Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model.

Authors:  S A Charman; D N McLennan; G A Edwards; C J Porter
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  The pharmacokinetics of two different concentrations of short-acting insulin, intermediate-acting insulin, and an insulin mixture following subcutaneous injection.

Authors:  A Hübinger; W Weber; W Jung; K Wehmeyer; F A Gries
Journal:  Clin Investig       Date:  1992-07

Review 3.  Insulin injection technique.

Authors:  J Thow; P Home
Journal:  BMJ       Date:  1990-07-07

4.  Modeling absorption kinetics of subcutaneous injected soluble insulin.

Authors:  E Mosekilde; K S Jensen; C Binder; S Pramming; B Thorsteinsson
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

Review 5.  Clinical use of U-500 regular insulin: review and meta-analysis.

Authors:  Sirimon Reutrakul; Kristen Wroblewski; Rebecca L Brown
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

6.  Sources of glycemic variability--what type of technology is needed?

Authors:  Jonas Kildegaard; Toke Folke Christensen; Ole Kristian Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

7.  A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: validation and simulation.

Authors:  Jason Wong; J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Thomas F Lotz; Jessica Lin; Aaron J Le Compte
Journal:  J Diabetes Sci Technol       Date:  2008-07

8.  Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Perriello; E Torlone; S Di Santo; C Fanelli; P De Feo; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

Review 9.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

10.  Study of porcine and human isophane (NPH) insulins in normal subjects.

Authors:  D R Owens; I R Jones; A J Birtwell; C T Burge; S Luzio; C J Davies; P Heyburn; L G Heding
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.